Statistics for NeoGenomics (id:5256 NEO)
Valuation metrics
Market cap
2.11B
Enterprise value
2.32B
Trailing P/E (ttm)
-23.44
Forward P/E
82.05
PEG ratio
82.05
Price/Sales (ttm)
3.27
Price/Book (mrq)
2.31
Enterprise Value/Revenue
3.61
Enterprise Value/EBITDA
-5,201.02
Overview
Shares outstanding
128.36M
Float
126.61M
Shares short
3.69M
% Held by insiders
5.00%
% Held by institutions
3.00%
Average volume (10 days)
944.79K
Average volume (90 days)
Price summary
52-Week low
12.77
52-Week high
20.94
52-Week change
-25.47%
Beta
1.18
50-Day moving average
15.66
200-Day moving average
15.08
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-12.07%
Operating margin
-8.39%
Operational effectiveness
Return on assets
-2.76%
Return on equity
-8.38%
Income statement
Revenue (ttm)
5.10
Revenue per share (ttm)
5.10
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
244.60M
EBITDA
-447,000.00
Net income to common (ttm)
-77,728,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
10.44%
Balance sheet
Total cash (mrq)
387.81M
Total cash per share (mrq)
3.02
Total debt (mrq)
606.27M
Total Debt/Equity (mrq)
66.75
Current ratio (mrq)
199.10%
Book value per share (mrq)
7.09
Cash flow
Cash flow statement
15.01M
Levered free cash flow (LFCF)
9.09M